Q4 2024 Earnings Call Transcript February 28, 2025 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.31. Operator: Greetings, and welcome to the Fulgent ...

Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.

Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from FY... EL MONTE, Calif., February 28, 2025--Fulgent Genetics, Inc. (NASDAQ ...

UBS analyst Dan Leonard lowered the firm’s price target on Fulgent Genetics (FLGT) to $20 from $27 and keeps a Neutral rating on the shares.

Piper Sandler analyst David Westenberg lowered the firm’s price target on Fulgent Genetics (FLGT) to $16 from $22 following quarterly results.

Fulgent Genetics (($FLGT)) has held its Q4 earnings call. Read on for the main highlights of the call. Fulgent Genetics’ recent earnings call ...

Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from ...

Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report) shares gapped up prior to trading on Thursday after an insider bought additional shares in the company. The stock had previously closed at $16.65 ...

StockNews.com upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a sell rating to a hold rating in a research report released on Wednesday. Separately, Piper Sandler decreased their ...

FULGENT GENETICS ($FLGT) posted quarterly earnings results on Friday, February 28th. The company reported earnings of $0.04 per share, beating estimates of -$0.13 by ...

Greetings and welcome to the Fulgent Genetics Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions]. A question-and-answer session ...